Water Island Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Water Island Capital’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-45,308	Closed	-$5.98M	–	115
2025 Q1	$5.98M	Buy	+45,308	New	+$5.65M	0.78%	32

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Water Island Capital's ITCI Position: Q2 2025 in Review

Water Island Capital sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 45,308 shares — an estimated $5.98M sold.

Water Island Capital first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $5.98M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Water Island Capital reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Water Island Capital sold 45,308 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $5.98M.
Water Island Capital first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
Water Island Capital's Intra-Cellular Therapies Inc. position peaked at $5.98M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Water Island Capital's 13F filing for Q2 2025, filed 14 Aug 2025.